Evidence map›Paper›PMID 37313072›Full record

ArticleCureus2023

Glucose and Lipid Profiles of Overweight and Obese Children in Riyadh, Saudi Arabia.

Mohammed A AlAteeq, AbdulAziz AlHusaini, AbdulAziz AlMalahi, Faisal AlOtay, Azzam AlTurki, AbdulAziz Alghafis

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammed A AlAteeqFamily Medicine, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, SAU.
AbdulAziz AlHusainiMedicine, King Saud Bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, SAU.
AbdulAziz AlMalahiMedicine, King Saud Bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, SAU.
Faisal AlOtayMedicine, King Saud Bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, SAU.
Azzam AlTurkiMedicine, King Saud Bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, SAU.
AbdulAziz AlghafisMedicine, King Saud Bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity is a prevalent issue worldwide, affecting both children and adults and posing significant health risks. Obesity and overweight are known to be associated with metabolic abnormalities among children and adolescents. This study aims to determine the metabolic profiles, identifying any abnormalities and related factors among overweight and obese children in Saudi Arabia (SA).

methodsThis study conducted a cross-sectional, descriptive, and analytical analysis on 382 overweight and obese children between the ages of seven and 14 years. The subjects were visitors to pediatric endocrinology clinics and primary healthcare clinics in King Abdulaziz Medical City (KAMC) in Riyadh, Saudi Arabia. Data from the electronic medical records between 2018 and 2020 were examined, focusing on total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and fasting blood sugar (FBS).

resultsAmong the study sample, 8% were found to have high TC, 19% had high LDL-C, 27% had low HDL-C, 12% had high TG, and 8% had high FBS. Overweight children had higher HDL levels, while obese children had higher TG levels. There was no significant difference between males and females or between different age groups in metabolic profiles.

conclusionThis study uncovered a low prevalence of abnormal lipid and FBS profiles among overweight and obese children and adolescents. Detecting and managing the early onset of dyslipidemia and hyperglycemia can prevent long-term consequences and safeguard children from the risk of future cardiovascular injuries and deaths.

Indexed as

atherosclerotic diseasedyslipidemiametabolic diseasespediatricsprevention

Identifiers

PMID37313072
PMCPMC10259743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.